NCT01938560View on ClinicalTrials.gov

REMS Retigabine Study

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions

Epilepsy

Interventions

OTHER

Survey Responses

Subject understanding of the risk of urinary retention and the symptoms of acute urinary retention associated with retigabine will be assessed using the survey instrument.